U.S. Markets closed

Pfizer’s Bosulif Had a Strong Performance in 4Q17 and 2017

Daniel Collins
Pfizer’s Bosulif Had a Strong Performance in 4Q17 and 2017

How Did Pfizer’s Oncology Business Perform in 2017?